You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoid Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,

Recruiting
  • Carcinoid Syndrome
  • +8 more
  • Randomized: 40 mg Paltusotine
  • Randomized: 80 mg Paltusotine
  • Newport Beach, California
  • +5 more
Jan 3, 2023

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

Active, not recruiting
  • Carcinoid Tumor
  • Pancreatic Neuroendocrine Tumor
  • Boston, Massachusetts
  • +1 more
Jul 15, 2022

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)

Recruiting
  • Carcinoid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 14, 2022

Small Bowel Cancer, Small Bowel Carcinoid Tumor, Quality of Life Trial in Lorenskog (Surgery with extended (D3) mesenterectomy

Recruiting
  • Small Bowel Cancer
  • +4 more
  • Surgery with extended (D3) mesenterectomy for small bowel tumors
  • Lorenskog, Norway
    Akershus University Hospital
Jan 3, 2023

Genetics of Appendix Cancer Study

Recruiting
  • Appendix Cancer
  • +14 more
  • Genetic profiling
  • Retrospective tissue procurement
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Feb 8, 2023

Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

Not yet recruiting
  • Carcinoid Tumor Lung
  • +2 more
  • 212-Lead Pentixather
  • 203-Lead Pentixather SPECT/CT
  • Iowa City, Iowa
    The University of Iowa Theranostics Center
Sep 23, 2022

68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

Recruiting
  • Neuroendocrine Tumor Carcinoid
  • +2 more
    • Milan, Italy
      IRCCS Istituto Europeo di Oncologia S.r.l.
    Jul 8, 2022

    Midgut Carcinoid Tumor, Biliary Stones Trial in Spain (Primary tumor surgery, Primary tumor surgery (bowel resection) combined

    Recruiting
    • Midgut Carcinoid Tumor
    • Biliary Stones
    • Primary tumor surgery
    • Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy
    • Badalona, Barcelona, Spain
    • +5 more
    Jul 6, 2022

    Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

    Active, not recruiting
    • Carcinoid Tumors
    • Boston, Massachusetts
    • +1 more
    Apr 14, 2022

    Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +18 more
    • Clinical Encounter
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jul 24, 2023

    Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

    Completed
    Has Results
    • Gastrinoma
    • +8 more
    • Scottsdale, Arizona
    • +4 more
    Nov 15, 2021

    Tricuspid Regurgitation, Tricuspid Valve Disease, Carcinoid Syndrome Trial in London (Transcatheter Tricuspid Valved Stent

    Not yet recruiting
    • Tricuspid Regurgitation
    • +3 more
    • Transcatheter Tricuspid Valved Stent Graft
    • London, England, United Kingdom
      Barts Health NHS Trust
    Apr 19, 2022

    Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

    Recruiting
    • Carcinoid Syndrome
    • +3 more
    • Dual-Energy Computed Tomography
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 28, 2021

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Neuroendocrine Tumors Trial (Telotristat Ethyl Oral Tablet)

    Withdrawn
    • Neuroendocrine Tumors
    • Telotristat Ethyl Oral Tablet
    • (no location specified)
    Dec 3, 2021

    Tumors, Tumor Metastasis, Metastatic Gastrointestinal Carcinoid Tumor Trial in China, United States (EMB-01)

    Recruiting
    • Neoplasms
    • +2 more
    • Canton, Ohio
    • +3 more
    Apr 12, 2022

    Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)

    Not yet recruiting
    • Metastatic Cancer
    • +7 more
    • Standard of Care Chemotherapy
    • +7 more
    • (no location specified)
    Apr 1, 2022

    Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

    Withdrawn
    • Neuroendocrine Tumors
    • +2 more
    • Telotristat ethyl
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospital and Clinics
    Feb 9, 2022